Concepedia

Lori R. Hilden

LR

4

Publications

129

Citations

4

H-Index

2003

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Eli Lilly (United States)

Lori R. Hilden is an author at Bristol-Myers Squibb (United States) specializing in drug analysis, chemistry, and engineering.

Top concepts

Publications per year

2003–2020

4

Publications

4

Applications of Quantum Chemistry in Pharmaceutical Process Development: Current State and Opportunities

Yu‐hong Lam, Yuriy A. Abramov, Ravi S. Ananthula et al. · Organic Process Research & Development · 2020 · 49 citations

, , +26

Particle engineering: A strategy for establishing drug substance physical property specifications during small molecule development

Ronald G. Iacocca, Christopher L. Burcham, Lori R. Hilden · Journal of Pharmaceutical Sciences · 2009 · 42 citations

, , +11

NIR chemical imaging to guide/support BMS-561389 tablet formulation development

Lori R. Hilden, C. Pommier, Sherif I.F. Badawy et al. · International Journal of Pharmaceutics · 2007 · 21 citations

, , +7

Prediction of the relaxation behavior of amorphous pharmaceutical compounds. I. Master curves concept and practice

Lori R. Hilden, Kenneth R. Morris · Journal of Pharmaceutical Sciences · 2003 · 17 citations

, , +11

Rows per page

1–4 of 4